Back to 
BALYASNY ASSET MANAGEMENT L.P.
BALYASNY ASSET MANAGEMENT L.P.
LXEO5 quarters
Position history for BALYASNY ASSET MANAGEMENT L.P.'s holdings in LEXEO THERAPEUTICS INC
Yes. Balyasny Asset Management holds 2,412,742 shares of LXEO (Lexeo Therapeutics), worth $11.2M, as of its Q2 2026 13F filing. It increased the position by 823,157 shares (+51.8%) from Q1 2026. Balyasny Asset Management has held LXEO since Q2 2025, across 5 quarterly 13F filings.
Current Value
$11.2M
Current Shares
2.4M
Total Value Change
-$4.9M
Total Shares Change
-1.6M
Quarter-by-Quarter History
Other major holders of LXEO: Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C.